WASHINGTON, DC – Energy and Commerce Committee members Rep. David McKinley (R-WV) and Rep. Debbie Dingell (D-MI) introduced legislation to specify drug distributer or manufacturer’s role when a suspicious order is received. Recently, the Washington Post released an article detailing the billions of opioid pills poured into the U.S. by drug companies. Although drug companies currently have a responsibility by law to report suspicious order to the Drug Enforcement Agency, McKinley’s and Dingell’s law, Block, Report, And Suspend Suspicious Shipments Act of 2019, would require companies to refuse shipment of the orders as well.
The Energy and Commerce Committee has been at the forefront of combatting the nation’s opioid crisis. Last Congress, the single largest effort to tackle a drug epidemic, the SUPPORT for Patients and Communities Act, went through E&C and was signed into law. Read the full article below on E&C member’s newly introduced legislation.
McKinley introduces bill to clarify how drug companies handle ‘suspicious orders’
A West Virginia Republican in the U.S. House of Representatives introduced a bill Tuesday to clarify requirements that drug distributors report suspicious orders of controlled substances to law enforcement and block those orders.
U.S. Rep. David McKinley and Rep. Debbie Dingell, D-Mich., introduced the ‘‘Block, Report, And Suspend Suspicious Shipments Act of 2019.”
Under current law, drug manufacturers, distributors and pharmacies are required to report orders that appear to be suspicious (by size or frequency) to the Drug Enforcement Agency. A congressional committee recently found drug shippers failed to adequately report or withhold those orders. However, some in the industry have argued the federal guidelines are too vague to follow.
“Between 2006 and 2012, more than 850 million opioid pills were shipped into small communities throughout West Virginia, these drugs have wreaked havoc on our communities and contributed to our state becoming the epicenter of the opioid epidemic,” McKinley said in a statement. “[Distributors] have continued to fall back on the fact that they flagged suspicious orders for the DEA, but what they fail to mention is that they continued to ship these orders even after flagging them as suspicious.”
Click here to read the full article